🇺🇸 FDA
Pipeline program

MORPHINE , PENTHROX 99,9%, liquide pour inhalation par vapeur de 3 mL

APHP 180610

Phase 3 small_molecule active

Quick answer

MORPHINE , PENTHROX 99,9%, liquide pour inhalation par vapeur de 3 mL for Acute Myocardial Infarction is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Acute Myocardial Infarction
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials